Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NUTX

NUTX - Nutex Health, Inc. Stock Price, Fair Value and News

$88.73+1.72 (+1.98%)
Market Closed

91/100

NUTX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

91/100

NUTX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NUTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NUTX Price Action

Last 7 days

-1.7%

Last 30 days

-13.8%

Last 90 days

-52.0%

Trailing 12 Months

94.2%

NUTX RSI Chart

NUTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NUTX Valuation

Market Cap

618.3M

Price/Earnings (Trailing)

2.92

Price/Sales (Trailing)

0.71

EV/EBITDA

1.71

Price/Free Cashflow

2.52

NUTX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NUTX Fundamentals

NUTX Revenue

Revenue (TTM)

875.3M

Rev. Growth (Yr)

-41.12%

Rev. Growth (Qtr)

-43.36%

NUTX Earnings

Earnings (TTM)

212.1M

Earnings Growth (Yr)

45.37%

Earnings Growth (Qtr)

61.79%

NUTX Profitability

Operating Margin

97.99%

EBT Margin

27.97%

Return on Equity

50.08%

Return on Assets

23.09%

Free Cashflow Yield

39.72%

NUTX Investor Care

Shares Dilution (1Y)

30.07%

Diluted EPS (TTM)

10.12

NUTX Alerts

  • Big fall in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025624.3M792.2M981.2M875.3M
2024258.8M275.9M292.0M479.9M
2023196.5M197.4M231.7M247.6M
2022323.3M318.5M229.0M219.3M
2021288.4M302.8M317.2M331.5M
202069.5M137.7M205.9M274.0M
20191.6M2.0M1.7M1.4M
2018359.1K695.1K1.0M1.4M
2017216.7K152.2K87.7K23.2K
2016410.2K345.7K281.2K0
20151.1M1.2M1.2M474.7K
20141.3M1.2M1.1M1.1M
20131.5M1.5M1.4M1.5M
20121.9M1.8M1.8M1.6M
20111.1M1.3M1.6M1.8M
2010000874.8K
Get all data in R, Python etc through our Historical Stock Data APIs

About Nutex Health, Inc.

NUTX
Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
 CEO
 WEBSITEnutexhealth.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES800

Nutex Health, Inc. Frequently Asked Questions

NUTX is the stock ticker symbol of Nutex Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Nutex Health, Inc. is 618.3 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, NUTX's PE ratio (Price to Earnings) is 2.92 and Price to Sales (PS) ratio is 0.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUTX PE ratio will change depending on the future growth rate expectations of investors.